Search research articles
Contact Us
Filters
Showing results (21-30 of 97) with videos related to
Page
of 10
Sort By:
Surgical Case Reports
|
May 17, 2022
Acute necrotizing calculous cholecystitis after treatment with ceftriaxone in an elderly patient: a case report
Tsunehiko Shigemori, Ichiro Imoto, Yasuhiro Inoue, et al.
Bioscience, Biotechnology, and Biochemistry
|
March 24, 2020
Plant growth regulators and Axl and immune checkpoint inhibitors from the edible mushroom <i>Leucopaxillus giganteus</i>
Irine Yunhafita Malya, Jing Wu, Etsuko Harada, et al.
Journal of Medicinal Food
|
December 21, 2017
The Medicinal Mushroom, Grifola gargal, Ameliorates Allergic Bronchial Asthma
Etsuko Harada, Corina N D'Alessandro-Gabazza, Masaaki Toda, et al.
Cancer Medicine
|
April 13, 2026
Endocrinologist-Led Management of Endocrine Immune-Related Adverse Events: Real-World Evidence Supporting the Japan Endocrine Society Guidelines
Kota Nishihama, Hajime Fujimoto, Kanako Saito, et al.
Diabetology International
|
August 5, 2024
A case of rapidly progressive insulin-dependent diabetes mellitus without islet autoantibodies developed over two years after the first dose of nivolumab
Kota Nishihama, Yuko Okano, Chisa Inoue, et al.
The Journal of Antibiotics
|
May 28, 2020
Axl and immune checkpoints inhibitors from fruiting bodies of Pleurocybella porrigens
Arif Yanuar Ridwan, Jing Wu, Etsuko Harada, et al.
Journal of Clinical Medicine
|
October 30, 2020
A Prediction Equation to Assess Resting Energy Expenditure in Japanese Patients with COPD
Keisuke Morikawa, Kazuyuki Tabira, Hiroyuki Takemura, et al.
Cells
|
September 28, 2021
Protective Role of Recombinant Human Thrombomodulin in Diabetes Mellitus
Yuko Okano, Atsuro Takeshita, Taro Yasuma, et al.
Oncology Research
|
January 12, 2018
A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer
Atsushi Fujiwara, Masamichi Yoshida, Hajime Fujimoto, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2022
Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report
Yoichi Nishii, Kazuki Furuhashi, Kentaro Ito, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 97) with videos related to
Sort By:
Page
of 10
Surgical Case Reports
|
May 17, 2022
Acute necrotizing calculous cholecystitis after treatment with ceftriaxone in an elderly patient: a case report
Tsunehiko Shigemori, Ichiro Imoto, Yasuhiro Inoue, et al.
Bioscience, Biotechnology, and Biochemistry
|
March 24, 2020
Plant growth regulators and Axl and immune checkpoint inhibitors from the edible mushroom <i>Leucopaxillus giganteus</i>
Irine Yunhafita Malya, Jing Wu, Etsuko Harada, et al.
Journal of Medicinal Food
|
December 21, 2017
The Medicinal Mushroom, Grifola gargal, Ameliorates Allergic Bronchial Asthma
Etsuko Harada, Corina N D'Alessandro-Gabazza, Masaaki Toda, et al.
Cancer Medicine
|
April 13, 2026
Endocrinologist-Led Management of Endocrine Immune-Related Adverse Events: Real-World Evidence Supporting the Japan Endocrine Society Guidelines
Kota Nishihama, Hajime Fujimoto, Kanako Saito, et al.
Diabetology International
|
August 5, 2024
A case of rapidly progressive insulin-dependent diabetes mellitus without islet autoantibodies developed over two years after the first dose of nivolumab
Kota Nishihama, Yuko Okano, Chisa Inoue, et al.
The Journal of Antibiotics
|
May 28, 2020
Axl and immune checkpoints inhibitors from fruiting bodies of Pleurocybella porrigens
Arif Yanuar Ridwan, Jing Wu, Etsuko Harada, et al.
Journal of Clinical Medicine
|
October 30, 2020
A Prediction Equation to Assess Resting Energy Expenditure in Japanese Patients with COPD
Keisuke Morikawa, Kazuyuki Tabira, Hiroyuki Takemura, et al.
Cells
|
September 28, 2021
Protective Role of Recombinant Human Thrombomodulin in Diabetes Mellitus
Yuko Okano, Atsuro Takeshita, Taro Yasuma, et al.
Oncology Research
|
January 12, 2018
A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer
Atsushi Fujiwara, Masamichi Yoshida, Hajime Fujimoto, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2022
Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report
Yoichi Nishii, Kazuki Furuhashi, Kentaro Ito, et al.
Page
of 10